What do you do if you start seeing worse? Most likely nothing. Age, you do not care that this can be a symptom of optic nerve atrophy, degenerative diseases of the retina of the eye, and you can not help glasses here … The world around becomes flat, a person can perceive colors differently, pain appears in his eyes, See any stains interfering, and if the disease is already progressing, then a person can not, as before, cover the entire «picture» in front of his eyes at a time — he needs to turn his eyes or head for this …
Retinal dystrophy is a serious disease associated with the gradual loss of photosensitive cells due to a disturbance in their nutrition. The nature of its occurrence by scientists has not been fully disclosed. Disease can begin to develop first on one eye, but later the other always joins. In far-reaching cases, the patient loses the ability to distinguish between the time of day (day and night), and later there comes complete blindness. Patients with retinal dystrophy often complain of double vision of visually perceived subjects, broken lines, the presence of blind spots in vision.
Macular degeneration of the retina is typical for people older than 50 years. The disease can lead to a complete loss of central vision. In this case, the peripheral vision of such a patient persists. Without a central vision, the sharpness of the perception of objects is impossible. People with retina dystrophy of this type of eye are not able to read or drive vehicles. The rate of progression of the disease depends on its type and severity. Wet form of the disease is considered to be the most severe, fast flowing and poorly treatable.
Pigmentary degeneration of the retina is the most rare anomaly caused by hereditary factors. It leads to violations in the work of photoreceptors of the retina, responsible either for twilight black and white, or for daytime color vision. In severe cases of pigmentary degeneration of the retina, complete fading in the visual function is possible.
Symptoms of partial atrophy of the optic nerve can be very different and have different severity. For example, narrowing the field of vision up to the tunnel syndrome, the presence of cattle (blind spots), reduced visual acuity. Atrophy of the optic nerve is precisely the disease with which one can not «flirt» at all, thinking that everything is formed by itself, this disease can only develop, leading to complete blindness.
Treatment of dystrophic eye diseases is mainly aimed at slowing the development of the disease. The prognosis for restoring visual acuity is unfavorable, therefore it is especially important to block the disease at an early stage, while vision can still be preserved. These problems are handled by leading ophthalmological clinics of Federal significance.
The fact that the eye is basically capable of regeneration is almost unknown to most ophthalmologists. In medicine, dogma continues to exist, that the neural tissue is not capable of regeneration. Therefore, the expressed atrophy of the retina and optic nerve is considered irreversible states.
In the case of visually impaired patients who have traveled a long way in trying not to improve, to save residual sight, hope has appeared — Professor Alexei V. Kovalev, who has been dealing with regenerative medicine for a long time, awarded the Nobel Medal «For the Development of Invention» for more than 10 years has been solving this problem . There are only one such people in Russia.
Professor Alexei Kovalyov received patents of the Russian Federation for new ways of returning vision at optic nerve atrophies, dystrophies and age-related macular degeneration of the retina, as well as central and peripheral taperotorhinal dystrophies (retinal abiotrophies).
The developed methods of treating the retina and optic nerve already today allow us to effectively restore vision even in blind and visually impaired patients. Patients are outpatiently operated under local anesthesia. Regenerative ophthalmology and biomedical technologies already today fundamentally change ophthalmology and representations of eye diseases, improving the quality of life of patients.